KIORA PHARMACEUTICALS CEO Stephen From's 2019 pay falls 40% to $601K

KIORA PHARMACEUTICALS reports 2019 executive compensation

By ExecPay News

Published: April 29, 2020

KIORA PHARMACEUTICALS reported fiscal year 2019 executive compensation information on April 29, 2020.
In 2019, four executives at KIORA PHARMACEUTICALS received on average a compensation package of $398K, a 28% decrease compared to previous year.
Average pay of disclosed executives at KIORA PHARMACEUTICALS
Stephen From, Chief Executive Officer, received $601K in total, which decreased by 40% compared to 2018. 67% of From's compensation, or $400K, was in salary. From also received $107K in bonus and $95K in option awards.
Michael Manzo, Vice President of Engineering, received a compensation package of $368K, which decreased by 14% compared to previous year. 68% of the compensation package, or $250K, was in salary.
Sarah Romano, Chief Financial Officer, earned $360K in 2019, a 3% increase compared to previous year.
Barbara Wirostko, Chief Medical Officer, received $262K in 2019, which decreases by 40% compared to 2018.

Related executives

Stephen From

KIORA PHARMACEUTICALS

Chief Executive Officer

Sarah Romano

KIORA PHARMACEUTICALS

Chief Financial Officer

Michael Manzo

KIORA PHARMACEUTICALS

Vice President of Engineering

Barbara Wirostko

KIORA PHARMACEUTICALS

Chief Medical Officer

You may also like

Source: SEC filing on April 29, 2020.